Mira Pharmaceuticals (MIRA) Share-based Compensation (2022 - 2025)

Mira Pharmaceuticals has disclosed Share-based Compensation across 4 years of filings, most recently posting $4.3 million for Q4 2025.

• Share-based Compensation for Q4 2025 came in at $4.3 million, up 686.42% year-over-year; the trailing twelve-month figure through Dec 2025 was $5.8 million (up 203.26% YoY), and the FY2025 annual result was $6.1 million, up 217.58% from the prior year.
• Share-based Compensation came in at $4.3 million for Q4 2025 at Mira Pharmaceuticals, up from $124972.0 in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $4.3 million in Q4 2025 to a low of $124972.0 in Q3 2025.
• The 4-year median for Share-based Compensation is $512699.0 (2024), against an average of $756594.5.
• Across the five-year window, Share-based Compensation soared 882.5% in 2023 and sank 81.47% in 2024, its largest moves.
• Mira Pharmaceuticals' Share-based Compensation stood at $147800.0 in 2022, then surged by 44.66% to $213813.0 in 2023, then surged by 155.73% to $546781.0 in 2024, then surged by 686.42% to $4.3 million in 2025.
• The last three Share-based Compensation figures came in at $4.3 million (Q4 2025), $124972.0 (Q3 2025), and $525188.0 (Q2 2025), per Business Quant data.